問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital

Division of Hematology & Oncology

更新時間:2023-09-19

連銘瑜
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2022-01-05 - 2026-01-06

Phase I/II

Completed
A Phase 1/2 Dose Escalation/Expansion Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
  • Condition/Disease

    Mesothelioma

  • Test Drug

    靜脈輸注液

Participate Sites
4Sites

Recruiting4Sites

2023-09-30 - 2026-06-30

Phase I

Active
A Phase I, Open-label, Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TRX-920 Oral Gel (10 mg and 30 mg) in Patients With Advanced Solid Tumors
  • Condition/Disease

    Advanced Solid Tumor

  • Test Drug

    TRX-920 Oral Gel 10 mg & 30 mg

Participate Sites
3Sites

Recruiting3Sites

2022-01-05 - 2026-01-06

Phase I/II

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites